Back
Keros Therapeutics Stock Price Chart
Wall Street's Worst Nightmare: Small Town Trader's AI Edge
See the AI advantage for everyday Americans.
Buy
62
KROS
Keros Therapeutics
Last Price:
52.52
Seasonality Move:
16.51%
7 Day Trial
ALL ACCESS PASS
$
7
Groundbreaking AI Developed In Small Georgia Town Destroys Wall Street
See the remarkable discovery.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing slight selling pressure.
Keros Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.69 | Buy |
| 20-day SMA: | 46.56 | Buy |
| 50-day SMA: | 47.86 | Buy |
| 200-day SMA: | 48.31 | Buy |
| 8-day EMA: | 49.23 | Buy |
| 20-day EMA: | 47.95 | Buy |
| 50-day EMA: | 49.04 | Buy |
| 200-day EMA: | 49.48 | Buy |
Keros Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.74 | Buy |
| Relative Strength Index (14 RSI): | 57.69 | Buy |
| Chaikin Money Flow: | -68279 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.38 - 49.46) | Buy |
| Bollinger Bands (100): | (46.84 - 63.04) | Sell |
Keros Therapeutics Technical Analysis
| Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Keros Therapeutics Stock
Is Keros Therapeutics Stock a Buy?
- Keros Therapeutics share price is 50.29 while KROS 8-day simple moving average is 49.69, which is a Buy signal.
- The stock price of KROS is 50.29 while Keros Therapeutics 20-day SMA is 46.56, which makes it a Buy.
- Keros Therapeutics 50-day simple moving average is 47.86 while KROS share price is 50.29, making it a Buy technically.
- KROS stock price is 50.29 and Keros Therapeutics 200-day simple moving average is 48.31, creating a Buy signal.
KROS Technical Analysis vs Fundamental Analysis
Buy
62
Keros Therapeutics (KROS)
is a Buy
Is Keros Therapeutics a Buy or a Sell?
-
Keros Therapeutics stock is rated a Buy
The current Keros Therapeutics [KROS] share price is $50.29. The Score for KROS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Keros Therapeutics Stock Info
Market Cap:
1.81B
Price in USD:
50.29
Share Volume:
212.64K
Keros Therapeutics 52-Week Range
52-Week High:
73.00
52-Week Low:
27.02
Buy
62
Keros Therapeutics (KROS)
is a Buy
Keros Therapeutics Share Price Forecast
-
What is the Keros Therapeutics stock price today?
The Keros Therapeutics stock price is 50.29 USD today. -
Will KROS stock go up or go down?
Keros Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Keros Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Keros Therapeutics is not overvalued.
Is Keros Therapeutics Stock a Buy?
- Keros Therapeutics share price is 50.29 while KROS 8-day exponential moving average is 49.23, which is a Buy signal.
- The stock price of KROS is 50.29 while Keros Therapeutics 20-day EMA is 47.95, which makes it a Buy.
- Keros Therapeutics 50-day exponential moving average is 49.04 while KROS share price is 50.29, making it a Buy technically.
- KROS stock price is 50.29 and Keros Therapeutics 200-day simple moving average is 49.48, creating a Buy signal.
Fundamental Analysis of Keros Therapeutics
Is Keros Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.
Technical Analysis of Keros Therapeutics
Should I short Keros Therapeutics stock?
- KROS Moving Average Covergence Divergence (MACD) indicator is 0.74, suggesting Keros Therapeutics is a Buy
- Keros Therapeutics Relative Strength Index (RSI) is 57.69, which suggest Keros Therapeutics is overbought
- The Bollinger Bands (25) for Keros Therapeutics is (43.38 - 49.46), which suggest Keros Therapeutics is a Sell
- The Bollinger Bands (100) for Keros Therapeutics is (46.84 - 63.04), which suggest Keros Therapeutics is a Sell
* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.